Spet ne bereš kaj objavljaš?
Conservative pundits, politicians and social media users are claiming that the U.S. Food and Drug Administration recentl
www.politifact.com
The agency has not changed its guidance on the drug. A spokesperson told PolitiFact that the FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19.
The federal agency has approved the use of ivermectin to treat humans with certain parasitic infections, such as pediculosis caused by head or body lice, or skin conditions, such as rosacea. The FDA urges people to take ivermectin only as prescribed by a health care provider.
Iverco lahko dobiš predpisano če imaš gliste, ne pa covida
Bi rekel, da ti ne beres, kaj objavljas oz objavljajo tvoji 'fact checkerji'. Tvoji smejkoti so pa ze zlajnani.
FDA je med Covidom PREPOVEDALA predpisovanje Ivermectina zdravnikom in posledicno so bili zdravniki tudi odpusceni.
Kar je FDA naredila je protizakonito, ker zdravniki lahko predpisujejo zdravila tudi za druge namene, ki niso nujno odobreni s strani FDA za ta specificini namen in temu se rece OFF-LABEL recept. To je normalna praksa in redno v uporabi. V tem primeru je bila prepovedana. Bom napisal spodaj zakaj.
Ivermectin je bil odobren s strani FDA leta 1966 (posledicno se ga lahko predpisuje off-label) in je leta 2015 prejel Nobelovo nagrado za zdravilo.
Pri nas, v Sloveniji, so sli se dlje in so celo PREPOVEDALI uvoz tega zdravila.
Kljub veckratnimi zavajanjem uporabnika
johan_blonda, da to ne drzi, je dejstvo, da so eksperimentalna cepiva lahko dobila EUA (Emergency Use Authorization) le v primeru, ce ne obstaja alternativno zdravljenje.
HidroksiChloroquine in Ivermectin sta predstavljala alternativni zdravljenji in zaradi tega ju je bilo potrebno eliminirati, drugace eksperimentalna cepiva ne bi mogla dobiti dovoljenja za uporabo.
Tako pa so, Big Pharma je zasluzila milijarde, po vas pa krozijo eksperimentalna cepiva (Pfizer in Moderna nista se uspela dokazati, da se sestavine cepiva izlocijo iz telesa.
Explains FDA's general recommendations and procedures applicable to authorization of the emergency use of certain medical products
www.fda.gov
d. No Alternatives
For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition. A potential alternative product may be considered “unavailable” if there are insufficient supplies of the approved alternative to fully meet the emergency need. A potential alternative product may be considered "inadequate" if, for example, there are contraindicating data for special circumstances or populations (e.g., children, immunocompromised individuals, or individuals with a drug allergy), if a dosage form of an approved product is inappropriate for use in a special population (e.g., a tablet for individuals who cannot swallow pills), or if the agent is or may be resistant to approved and available alternative products.
Se obvezni video z razlago:
lokalec.si
